Atalanta Sosnoff Capital’s Pfizer PFE Stock Holding History

Atalanta Sosnoff Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$575K	Sell	23,858 -2,489	-9%	-$65.1K	0.01%	76
2026 Q1	$740K	Buy	26,347 +28	+0.1%	+$745	0.02%	70
2025 Q4	$655K	Sell	26,319 -444	-2%	-$11.2K	0.01%	70
2025 Q3	$682K	Buy	+26,763	New	+$661K	0.01%	73
2025 Q2	–	Sell	-13,702	Closed	-$347K	–	109
2025 Q1	$347K	Sell	13,702 -1,341	-9%	-$35.1K	0.01%	86
2024 Q4	$399K	Buy	+15,043	New	+$408K	0.01%	76
2022 Q1	–	Sell	-17,700	Closed	-$1.04M	–	124
2021 Q4	$1.04M	Buy	+17,700	New	+$877K	0.02%	80
2021 Q1	–	Sell	-206,155	Closed	-$7.59M	–	109
2020 Q4	$7.59M	Sell	206,155 -7,679	-4%	-$282K	0.19%	68
2020 Q3	$7.45M	Buy	+213,834	New	+$7.5M	0.21%	71
2019 Q3	–	Sell	-730,573	Closed	-$30M	–	104
2019 Q2	$30M	Sell	730,573 -194,576	-21%	-$7.73M	0.95%	46
2019 Q1	$37.3M	Buy	925,149 +170,972	+23%	+$6.85M	1.17%	41
2018 Q4	$31.2M	Buy	754,177 +84,108	+13%	+$3.49M	1.14%	35
2018 Q3	$28M	Sell	670,069 -4,145	-0.6%	-$160K	0.84%	46
2018 Q2	$23.2M	Sell	674,214 -7,760	-1%	-$265K	0.76%	46
2018 Q1	$23M	Sell	681,974 -19,839	-3%	-$682K	0.77%	46
2017 Q4	$24.1M	Sell	701,813 -14,575	-2%	-$497K	0.78%	49
2017 Q3	$24.3M	Sell	716,388 -13,910	-2%	-$447K	0.84%	49
2017 Q2	$23.3M	Sell	730,298 -72,502	-9%	-$2.29M	0.82%	53
2017 Q1	$26.1M	Buy	802,800 +131,953	+20%	+$4.16M	0.91%	51
2016 Q4	$20.7M	Sell	670,847 -598,239	-47%	-$18.3M	0.74%	54
2016 Q3	$40.8M	Sell	1,269,086 -114,503	-8%	-$3.83M	1.41%	33
2016 Q2	$46.2M	Sell	1,383,589 -50,481	-4%	-$1.61M	1.54%	26
2016 Q1	$40.3M	Sell	1,434,070 -605,941	-30%	-$17.3M	1.27%	34
2015 Q4	$62.5M	Buy	2,040,011 +220,417	+12%	+$6.93M	1.86%	20
2015 Q3	$54.2M	Buy	1,819,594 +1,755,263	+2,728%	+$56.3M	1.73%	24
2015 Q2	$2.05M	Sell	64,331 -14,570	-18%	-$475K	0.06%	75
2015 Q1	$2.6M	Buy	78,901 +553	+0.7%	+$17.6K	0.07%	67
2014 Q4	$2.32M	Buy	78,348 +10,303	+15%	+$295K	0.06%	68
2014 Q3	$1.91M	Sell	68,045 -1,478,155	-96%	-$41.5M	0.05%	65
2014 Q2	$43.5M	Sell	1,546,200 -2,012,022	-57%	-$57.4M	0.95%	45
2014 Q1	$108M	Sell	3,558,222 -4,257	-0.1%	-$127K	2.42%	17
2013 Q4	$104M	Buy	3,562,479 +405,014	+13%	+$11.8M	2.23%	16
2013 Q3	$86.1M	Sell	3,157,465 -498,007	-14%	-$13.6M	2.27%	16
2013 Q2	$97.1M	Buy	+3,655,472	New	+$101M	2.35%	17

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Atalanta Sosnoff Capital's PFE Position: Q2 2026 in Review

Atalanta Sosnoff Capital reduced its Pfizer (PFE) stake by 9.4% in Q2 2026, selling an estimated $65.1K and leaving 23,858 shares worth $575K. The position accounts for 0.01% of the portfolio, ranked #76.

Atalanta Sosnoff Capital first reported a position in PFE in Q2 2013 and has held it in 34 quarters since. The position peaked at $108M in Q1 2014. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Atalanta Sosnoff Capital held 23,858 shares of Pfizer worth $575K as of Q2 2026.
Atalanta Sosnoff Capital sold 2,489 Pfizer shares in Q2 2026, an estimated $65.1K.
Pfizer made up 0.01% of Atalanta Sosnoff Capital's portfolio in Q2 2026, its #76 holding.
Atalanta Sosnoff Capital first reported a position in Pfizer in Q2 2013 and has held it in 34 quarters since.
Atalanta Sosnoff Capital's Pfizer position peaked at $108M in Q1 2014.
2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Atalanta Sosnoff Capital's 13F filing for Q2 2026, filed 12 Aug 2026.